EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis and biological evaluation of 1,2,3-Triazole ring incorporated (1,3,4-thiadiazol-2-yl)pyrimidin-5-yl)-3-(4-nitrophenyl)-1,2,4-thiadiazole derivatives as anticancer agents

Batta Kondala Rao, Reddymasu Sreenivasulu, Somaiah Nalla, Kiranmayi Peddi

Chemical Data Collections · 2026-03 · 62 · 101232

DOI: 10.1016/j.cdc.2026.101232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Data Collections, 2026-03. Verfasst von Batta Kondala Rao und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rao, B. K., Sreenivasulu, R., Nalla, S., & Peddi, K. (2026). Design, synthesis and biological evaluation of 1,2,3-Triazole ring incorporated (1,3,4-thiadiazol-2-yl)pyrimidin-5-yl)-3-(4-nitrophenyl)-1,2,4-thiadiazole derivatives as anticancer agents. Chemical Data Collections, 62, 101232. https://doi.org/10.1016/j.cdc.2026.101232

Vancouver

Rao BK, Sreenivasulu R, Nalla S, Peddi K. Design, synthesis and biological evaluation of 1,2,3-Triazole ring incorporated (1,3,4-thiadiazol-2-yl)pyrimidin-5-yl)-3-(4-nitrophenyl)-1,2,4-thiadiazole derivatives as anticancer agents. Chemical Data Collections. 2026;62:101232. doi:10.1016/j.cdc.2026.101232

BibTeX
@article{Rao2026,
  author = {Rao, Batta Kondala and Sreenivasulu, Reddymasu and Nalla, Somaiah and Peddi, Kiranmayi},
  title = {Design, synthesis and biological evaluation of 1,2,3-Triazole ring incorporated (1,3,4-thiadiazol-2-yl)pyrimidin-5-yl)-3-(4-nitrophenyl)-1,2,4-thiadiazole derivatives as anticancer agents},
  journal = {Chemical Data Collections},
  year = {2026},
  volume = {62},
  pages = {101232},
  doi = {10.1016/j.cdc.2026.101232}
}
Kostenlos starten →